The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
History and the motivation to make money say you’re spot on. Despite that, I’m still happy to be opening up new pathways for pain reduction. I’m hoping for the best for this and other options.
History and the motivation to make money say you’re spot on. Despite that, I’m still happy to be opening up new pathways for pain reduction. I’m hoping for the best for this and other options.